Profiles for generic drugs starting with 'n'
✉ Email this page to a colleague
US Patents and Regulatory Information for n
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Taro | NYSTATIN | nystatin | CREAM;TOPICAL | 064022-001 | Jan 29, 1993 | AT | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Rising | NITAZOXANIDE | nitazoxanide | TABLET;ORAL | 213820-001 | Nov 27, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Alvogen | NEVIRAPINE | nevirapine | TABLET, EXTENDED RELEASE;ORAL | 204621-002 | Nov 9, 2015 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Elite Pharm Solution | NIFEDIPINE | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 212016-001 | Nov 18, 2020 | AB2 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |